MIMOZA ZAKA: Open Payments
NPI 1053786954 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 17 payments from 16 companies in 2025. Trend: 2023 $2,349 · 2024 $2,273 · 2025 $1,789
Food & beverage: $1,789
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $258 |
| Averitas Pharma Inc. | 1 | $145 |
| Medtronic, Inc. | 1 | $132 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $107 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
Products named: QUTENZA, UZEDY, SYMPLICITY G3, AUSTEDO XR, PYRUKYND, REXULTI, Wegovy, EPIDIOLEX.
Industry payments across MI — which companies pay providers there.
